We are live on ! Find out more
SCI

S&CO Inc Portfolio holdings

AUM $1.61B
1-Year Est. Return 21.39%
This Fund
S&P 500
This Quarter Est. Return
+1.42%
1 Year Est. Return
+21.39%
3 Year Est. Return
+58.88%
5 Year Est. Return
+84.19%
10 Year Est. Return
+267.05%
AUM
$1.49B
AUM Growth
+$16.4M
Cap. Flow
+$17.1M
Cap. Flow %
1.15%
Top 10 Hldgs %
38.39%
Holding
221
New
11
Increased
53
Reduced
54
Closed
4

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$4.62M
2
UNH icon
UnitedHealth
UNH
+$3.99M
3
DBRG icon
DigitalBridge
DBRG
+$2.39M
4
MRK icon
Merck
MRK
+$2.17M
5
AMZN icon
Amazon
AMZN
+$2.01M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$6.62M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.27M
3
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$3.11M
4
PPLI
People Inc
PPLI
+$1.63M
5
JNJ icon
Johnson & Johnson
JNJ
+$1.41M

Sector Composition

Rank Sector Weight
1 Healthcare 17.45%
2 Technology 17.44%
3 Financials 11.3%
4 Materials 10.73%
5 Communication Services 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOGL icon
26
Alphabet (Google) Class A
GOOGL
$3.91T
$14.8M 0.99%
95,662
-5,401
-5% -$980K
PEP icon
27
PepsiCo
PEP
$186B
$14.7M 0.99%
97,909
-5,537
-5% -$824K
LIN icon
28
Linde
LIN
$237B
$12.2M 0.82%
26,280
-44
-0.2% -$19.8K
PYPL icon
29
PayPal
PYPL
$49.5B
$12.2M 0.82%
187,119
+6,501
+4% +$506K
LLYVK icon
30
Liberty Live Group Series C
LLYVK
$9.11B
$12M 0.8%
175,945
+730
+0.4% +$52.1K
AR icon
31
Antero Resources
AR
$10.9B
$11.9M 0.8%
293,788
+10,205
+4% +$391K
PANW icon
32
Palo Alto Networks
PANW
$264B
$11.3M 0.76%
66,304
– –
RPRX icon
33
Royalty Pharma
RPRX
$26.1B
$11.1M 0.75%
358,167
+5
+0% +$158
FWONK icon
34
Liberty Media Series C
FWONK
$24.3B
$11M 0.74%
121,857
– –
CSCO icon
35
Cisco
CSCO
$450B
$10.8M 0.73%
175,103
– –
APO icon
36
Apollo Global Management
APO
$70.7B
$10.7M 0.72%
77,880
– –
MIDD icon
37
Middleby
MIDD
$6.05B
$10.2M 0.68%
66,825
– –
MDT icon
38
Medtronic
MDT
$107B
$9.91M 0.67%
110,270
-8,253
-7% -$739K
LILA icon
39
Liberty Latin America Class A
LILA
$1.51B
$9.82M 0.66%
2,284,342
-23,839
-1% -$109K
LLY icon
40
Eli Lilly
LLY
$1.07T
$9.63M 0.65%
11,660
+5,550
+91% +$4.62M
AFL icon
41
Aflac
AFL
$63.9B
$9.25M 0.62%
83,170
-500
-0.6% -$53K
ABNB icon
42
Airbnb
ABNB
$83.7B
$9.24M 0.62%
77,355
– –
XBI icon
43
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$8.48M 0.57%
104,573
-34,802
-25% -$3.11M
ROL icon
44
Rollins
ROL
$18.6B
$8.43M 0.57%
156,098
– –
P
45
Everpure Inc
P
$24.8B
$8.43M 0.57%
190,420
– –
NVDA icon
46
NVIDIA
NVDA
$5.01T
$8.14M 0.55%
75,132
+277
+0.4% +$35.1K
GE icon
47
GE Aerospace
GE
$367B
$8.05M 0.54%
40,208
-495
-1% -$97.4K
PPLI
48
People Inc
PPLI
$3.1B
$7.7M 0.52%
204,268
-44,621
-18% -$1.63M
HD icon
49
Home Depot
HD
$332B
$7.63M 0.51%
20,806
– –
ALKS icon
50
Alkermes
ALKS
$8.82B
$7.33M 0.49%
221,960
+7,495
+3% +$244K
1
2
3 4 5

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
PPW
Parcion Private Wealth Bellevue, Washington $1.61B AUM 31.08% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
RC
Roundview Capital Princeton, New Jersey $1.61B AUM 16.92% 1-Year Est. Return
TLFA
True Link Financial Advisors San Francisco, California $1.62B AUM 8.33% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

S&CO Inc's Q1 2025 Portfolio in Review

As of Q1 2025, S&CO Inc held 221 positions worth $1.49B, up 1.1% from $1.47B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

S&CO Inc's Q1 2025 filing shows 11 new, 53 increased, 54 reduced and 4 closed positions. Its largest new stake was Vertex Pharmaceuticals: 4,103 shares worth $1.99M. The largest sale was Apple, an estimated $6.62M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • S&CO Inc's largest Q1 2025 buy was Vertex Pharmaceuticals: 4,103 shares worth $1.99M.
  • S&CO Inc added most to Eli Lilly in Q1 2025, an estimated $4.62M increase.
  • S&CO Inc's biggest Q1 2025 reduction was Apple, cutting an estimated $6.62M.
  • S&CO Inc fully exited West Pharmaceutical in Q1 2025, selling an estimated $851K.
  • S&CO Inc's ten largest holdings make up 38% of its $1.49B portfolio in Q1 2025.
  • S&CO Inc opened 11 new positions and closed 4 in Q1 2025.
  • S&CO Inc's portfolio value rose 1.1% quarter-over-quarter to $1.49B.

Based on S&CO Inc's 13F filing for Q1 2025, filed 8 May 2025.